Basal glucometabolic status has an impact on long‐term prognosis following an acute myocardial infarction in non‐diabetic patients
- 9 October 2003
- journal article
- website
- Published by Wiley in Journal of Internal Medicine
- Vol. 254 (5) , 494-503
- https://doi.org/10.1046/j.1365-2796.2003.01221.x
Abstract
Tenerz Å, Nilsson G, Forberg R, Öhrvik J, Malmberg K, Berne C, Leppert J (Central Hospital, Västerås; Karolinska Hospital, Stockholm; and University Hospital, Uppsala; Sweden) Basal glucometabolic status has an impact on long‐term prognosis following an acute myocardial infarction in non‐diabetic patients. J Intern Med 2003; 254: 494–503. Objectives. Patients with diabetes are known to have a worse prognosis after an acute myocardial infarction (AMI) compared with non‐diabetic patients. The primary aim of this study was to investigate the effect of glucometabolic status on long‐term prognosis in non‐diabetic patients with an AMI. The second aim was to evaluate the extent to which blood glucose levels at admission depended on acute stress, assessed as serum cortisol, previous glucometabolic status, measured as haemoglobin A1c (HbA1c), or both. Design. In a prospective study of patients with an AMI, blood glucose, HbA1c and cortisol were measured at admission. Fasting blood glucose was determined before discharge and also afterwards, if necessary, for classification. Patients were followed‐up for 5.5 years. Subjects. Of the 305 consecutive patients 24% were diagnosed as diabetic and 76% as non‐diabetic. Main outcome measures. Death or non‐fatal myocardial re‐infarction. Results. In non‐diabetic patients, a Cox regression model was used. With death or re‐infarction as endpoint, the following prognostic factors had an impact on event‐free survival: age (P < 0.001), HbA1c (P = 0.002), cortisol (P < 0.001) and thrombolytic treatment (P = 0.001). There was a correlation between cortisol and blood glucose at admission (r = 0.44, P < 0.001). Fasting blood glucose day 5 showed no association with event‐free survival. Conclusions. In non‐diabetic patients with AMI, admission HbA1c and cortisol were predictors for 5.5‐year survival without recurrent non‐fatal myocardial infarction. The glucometabolic status of importance for prognosis was detected by HbA1c but not by fasting blood glucose or admission blood glucose, of which the latter was influenced by cortisol.Keywords
This publication has 33 references indexed in Scilit:
- Accelerating impact of diabetes mellitus on mortality in the years following an acute myocardial infarctionEuropean Heart Journal, 1999
- Elevated glycated haemoglobin in non-diabetic patients is associated with an increased mortality in myocardial infarctionPublished by Oxford University Press (OUP) ,1998
- A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin LevelsJAMA, 1996
- Mortality, Place and Mode of Death and Reinfarction during a Period of 5 Years after Acute Myocardial Infarction in Diabetic and Non-Diabetic PatientsCardiology, 1996
- Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: A statewide studyAmerican Heart Journal, 1995
- Plasma corticotrophin releasing hormone, vasopressin, ACTH and Cortisol responses to acute myocardial infarctionClinical Endocrinology, 1994
- Serum cortisol levels predict infarct size and patient mortalityInternational Journal of Cardiology, 1992
- Adrenocortical function in old age as reflected by plasma cortisol and ACTH test during the course of acute myocardial infarctionArchives of Gerontology and Geriatrics, 1988
- Estimation of infarct size with MB rather than total CKInternational Journal of Cardiology, 1983
- Serum Cortisol, Plasma Free Fatty Acids, and Urinary Catecholamines as Indicators of Complications in Acute Myocardial InfarctionCirculation, 1972